X.-G. Li, L. T. Kanerva / Tetrahedron: Asymmetry 18 (2007) 2468–2472
2471
of the chemical shifts when necessary. Mass spectra were
taken on a VG 7070E mass spectrometer. Optical rotations
were determined with a Perkin–Elmer polarimeter, and [a]D
obtained by changing the eluent to petroleum ether/ethyl
acetate (4:1).
values are given in units of 10ꢀ1 deg cm2 gꢀ1
.
Compound (S)-3a (676 mg, 2.39 mmol, ee = 89%) was dis-
solved in DIPE (48 mL), and BuOH (356 mg, 4.80 mmol)
and PS-D (30 mg mLꢀ1) were added. The reaction was
stopped after 1.7 h by filtering off the enzyme at 92% con-
version. The solvent was evaporated off and the residue
separated on a silica gel column as above to afford (S)-2a
(421 mg, 1.98 mmol, isolated yield 90%, ee(S)-2a = 99%)
and (R)-3a (50 mg, 0.18 mmol, ee(R)-3a = 80%).
4.2. Preparation of racemic rac-2a and rac-2b
Compound rac-1a (240 mg, 1.31 mmol) was dissolved in
tetrahydrofuran (3 mL) and paraformaldehyde (44 mg,
1.48 mmol), K2CO3 (18 mg, 0.13 mmol) and H2O
(124 mg, 6.89 mmol) were added. The suspension was
sonicated for 2 h. The solvent was evaporated off and the
residue dissolved in diethyl ether (6 mL), dried over
anhydrous Na2SO4 and filtered. After evaporation, the res-
idue was purified on a silica gel column eluting with ethyl
acetate/petroleum ether (4:1, v/v) to afford rac-2a as a solid
4.4. Preparation of (3R,4R)- and (3S,4S)-2b by
lipase-catalyzed acylation/deacylation
1
(258 mg, 1.21 mmol, yield 92%, mp 72–73 ꢁC). H NMR
Compound rac-2b (490 mg, 2.51 mmol) was dissolved in
toluene (50 mL), and lipase PS-D (15 mg mLꢀ1) and vinyl
butanoate (1.1 g, 10.00 mmol) were added. The reaction
was stopped after 2.3 h by filtering off the enzyme at 58%
conversion. The solvent was evaporated off and the residue
purified on a silica gel column with petroleum ether/ethyl
(500 MHz, CDCl3) d 3.58 (br s, 1H, OH), 4.43–4.45 (d,
J = 11.5 Hz, 1H), 5.18–5.21 (m, 2H), 7.32–7.48 (m, 5H,
arom.); 13C NMR (126 MHz, CDCl3) d 63.60, 67.48–
67.89 (t, J = 25.2 Hz), 118.19–122.83 (t, J = 293.0 Hz),
127.13, 127.99, 129.11, 129.96, 161.24–161.73 (t,
J = 31.4 Hz). HRMS: M+ found (M+ calcd for
C10H9F2NO2) 213.060200 (213.060135); MS: m/z (relative
intensity) 213 (0.15), 183 (2), 140 (100), 104 (6).
acetate (8:1) to afford (3S,4S)-3b (373 mg, 1.41 mmol,
22
isolated yield 96%, ee(3S,4S)-3b = 70%, ½aꢁD ¼ ꢀ6:0 (c 0.80,
1
CHCl3)) as an oily product. H NMR (500 MHz, CDCl3)
d 0.90–0.93 (t, J = 7.5 Hz, 3H), 1.56–1.62 (m, 2H), 2.22–
2.30 (m, 2H), 4.79–4.81 (dd, J = 11.5 Hz, 2.0 Hz, 1H),
4.87–4.89 (d, J = 11.0 Hz, 1H), 5.22–5.33 (dd,
J = 54.0 Hz, 2.0 Hz, 1H), 5.35–5.37 (d, J = 11.0 Hz, 1H),
7.28–7.33 (m, 2H), 7.39–7.46 (m, 3H). HRMS: M+ found
(M+ calcd for C14H16FNO3) 265.113700 (265.111422);
MS: m/z (relative intensity) 265 (0.05), 178 (6), 135 (23),
122 (100), 91 (10), 77 (3). (3R,4R)-2b (202 mg, 1.03 mmol,
isolated yield 98%, ee(3R,4R)-2b = 99%) was obtained by
changing the eluent to petroleum ether/ethyl acetate (1:1).
Using the above procedure, rac-2b was obtained as a semi-
solid product in 90% isolated yield. H NMR (500 MHz,
1
CDCl3) d 4.12 (br s, 1H, OH), 4.23–4.25 (d, J = 11.5 Hz,
1H), 4.91–4.94 (dd, J = 11.0 Hz, 1.0 Hz, 1H), 5.12–5.14
(d, J = 11.5 Hz, 1H), 5.17–5.29 (dd, J = 54.0 Hz, 1.5 Hz,
1H), 7.30–7.48 (m, 5H, arom.); 13C NMR (126 MHz,
CDCl3) d 61.75–61.94 (d, J = 23.9 Hz), 63.71–63.73 (d,
J = 2.5 Hz), 96.73–98.53 (d, J = 226.4 Hz), 126.76,
129.27, 129.35, 134.31, 164.44, 164.62 (d, J = 22.6 Hz).
HRMS: M+ found (M+ calcd for C10H10FNO2)
195.069700 (195.069557); MS: m/z (relative intensity) 195
(0.03), 178 (3), 135 (3), 122 (100), 91 (4), 77 (5).
Compound (3S,4S)-3b (360 mg, 1.36 mmol, ee = 70%) was
dissolved in DIPE (27 mL), and BuOH (200 mg,
2.70 mmol) and PS-D (30 mg mLꢀ1) were added. The reac-
tion was stopped after 4.2 h by filtering off the enzyme at
83% conversion. The solvent was evaporated off and the
residue was separated on a silica gel column as above to
afford (3S,4S)-2b (199 mg, 1.02 mmol, isolated yield 90%,
ee(3S,4S)-2b = 99%) and unreacted (3R,4R)-3b (60 mg,
0.23 mmol, ee(3R,4R)-3b = 71%).
4.3. Preparation of (R)- and (S)-2a by lipase-catalyzed
acylation/deacylation
Compound rac-2a (1.0 g, 4.70 mmol) was dissolved in tol-
uene (94 mL), and lipase PS-D (20 mg mLꢀ1) and vinyl
butanoate (2.1 g, 18.80 mmol) were added. The reaction
was stopped after 1 h by filtering off the enzyme at 53%
of the conversion. The solvent was evaporated off and
the residue purified on a silica gel column with petroleum
ether/ethyl acetate (12:1) to afford (S)-3a {676 mg,
4.5. Preparation of (R)- and (S)-2c by lipase-catalyzed
acylation/deacylation
2.39 mmol, isolated yield, 96%, mp 54–55 ꢁC, ee(S)-3a
=
22
89%, ½aꢁD ¼ þ49:1 (c 0.65, CHCl3)}. 1H NMR
(500 MHz, CDCl3) d 0.90–0.93 (t, J = 7.5 Hz, 3H), 1.56–
1.63 (m, 2H), 2.20–2.31 (m, 2H), 5.00–5.02 (d,
J = 11.5 Hz, 1H), 5.05–5.07 (dd, J = 8.0, 2.5 Hz, 1H),
5.43–5.46 (d, J = 11.5 Hz, 1H), 7.31–7.33 (m, 2H), 7.44–
7.46 (m, 3H). 13C NMR (126 MHz, CDCl3) d 13.53,
18.06, 35.53, 62.44 (t, J = 2.5 Hz), 69.74 (t, J = 23.9 Hz),
121.04, 128.09, 129.08, 130.02, 130.11, 161.08, 173.05.
HRMS: M+ found (M+ calcd for C14H15F2NO3)
283.102700 (283.102000); MS: m/z (relative intensity) 283
(0.01), 206 (0.05), 153 (5), 140 (100), 91 (4). (R)-2a
(447 mg, 2.10 mmol, isolated yield 95%, ee = 99%) was
Compound rac-2c (1.2 g, 6.72 mmol) was dissolved in tolu-
ene (134 mL), and lipase PS-D (15 mg mLꢀ1) and vinyl
butanoate (3.1 g, 26.89 mmol) were added. The reaction
was stopped after 1.5 h by filtering off the enzyme at 51%
of the conversion. The solvent was evaporated off and
the residue purified on a silica gel column with petroleum
ether/ethyl acetate (6:1) to afford an oily product (R)-3c
{820 mg, 3.32 mmol, isolated yield 97%, ee(R)-3c = 94%,
22
½aꢁD ¼ þ61:3 (c 1.00, EtOH)}. (S)-2c (554 mg, 3.13 mmol,
isolated yield 95%, ee(S)-2c = 99%, mp 85–87 ꢁC) was ob-
tained by changing the eluent to petroleum ether/ethyl ace-
tate (1:3). The spectroscopic data are as reported.14